United Kingdom (GB)

Explainable AI for Operational Research: A defining framework, methods, applications, and a research agenda (2023) De Bock KW, Coussement K, Caigny AD, Słowiński R, Baesens B, Boute RN, Choi TM, et al. Journal article Flow Measurement (2023) Thorn R, Melling A, Köchner H, Haak R, Husain ZD, Wass DJ, Wadlow D, et al. Authored book Prenatal diagnosis of hypoplastic left heart syndrome on ultrasound using artificial intelligence: How does performance compare to a current screening programme? (2023) Day TG, Budd S, Tan J, Matthew J, Skelton E, Jowett V, Lloyd D, et al. Journal article Comment on: Magalhães et al., Middle Jurassic multi-scale transgressive–regressive cycles: An example from the Lusitanian Basin, The Depositional Record, 9, 174–202 (2023) Schneider S, Fürsich F, Werner W, Pierce CS Journal article EFAS/EAN survey on the influence of the COVID-19 pandemic on European clinical autonomic education and research (2023) Fanciulli A, Skorić MK, Leys F, Carneiro DR, Campese N, Calandra-Buonaura G, Camaradou J, et al. Journal article Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical practice guideline (2023) Duncan HF, Kirkevang LL, Peters OA, El-Karim I, Krastl G, Del Fabbro M, Chong BS, et al. Journal article Hippocampal neurons code individual episodic memories in humans (2023) Kolibius LD, Roux F, Parish G, Ter Wal M, Van Der Plas M, Chelvarajah R, Sawlani V, et al. Journal article Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline (2023) Veronese N, Soysal P, Demurtas J, Solmi M, Bruyère O, Christodoulou N, Ramalho R, et al. Journal article Unravelling the Molecular Structure and Confining Environment of an Organometallic Catalyst Heterogenized within Amorphous Porous Polymers** (2023) Jabbour R, Ashling CW, Robinson TC, Khan AH, Wisser D, Berruyer P, Ghosh AC, et al. Journal article Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study. (2023) Schett G, Chen W, Gao S, Chakravarty SD, Shawi M, Lavie F, Zimmermann M, et al. Journal article, Erratum